EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtMetaanalyseOpen Access · CC BY-NC 3.0

Diagnostic Performance of Circulating miRNA-92a and Related Circulating miRNA Panels for Colorectal Cancer: An Updated Systematic Review and Meta-Analysis

Rosmeri Handayani iD, Siti Hamidatul Aliyah iD, Muhammad Begawan Bestari, Reno Rudiman iD, Ninik Sukartini, Ida Parwati iD

OncoTargets and Therapy · 2026-03 · Volume 19 · 1-16

DOI: 10.2147/ott.s571818 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift OncoTargets and Therapy, 2026-03. Verfasst von Rosmeri Handayani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral Program of Medical Science, Faculty of Medicine, Universitas Padjadjaran, Sumedang-Bandung, West Java, Indonesia. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Colorectal cancer (CRC) is the second leading cause of cancer-related mortality worldwide and the third most frequently diagnosed malignancy. Circulating microRNAs, particularly miRNA-92a, have gained prominence as non-invasive biomarkers due to their stability in biological fluids and disease-specific expression patterns.

Objective

This study evaluates the diagnostic performance of circulating miRNA-92a for non-invasive colorectal cancer detection, both as an individual biomarker and in combination with other circulating miRNAs, including markers that are either members of the miRNA-92a family or unrelated miRNA candidates.

Methods

This review was registered in PROSPERO (CRD420251070402). A systematic search of PubMed, ScienceDirect, and Google Scholar was conducted for articles published up to May 2025 in accordance with PRISMA guidelines. Eligible articles evaluated circulating miRNA92a for CRC diagnosis, used appropriate reference standards, and reported extractable sensitivity and specificity data. A bivariate random-effects model in STATA/BE v18.0 was used to generate pooled estimates of sensitivity, specificity, PLR, NLR, logDOR, and AUC. Study quality was assessed using QUADAS-2, and publication bias was examined with Deeks' funnel plot asymmetry test.

Results

Twenty-two studies from sixteen articles, involving 1918 CRC patients and 1446 healthy controls, were included. Circulating miRNA-92a and miRNA-92a-related circulating panels demonstrated pooled sensitivity and specificity of 86% and 91%. Overall diagnostic performance was high, with an AUC of 0.87. The logDOR was 3.71, with a pooled PLR of 18.54 and an NLR of 0.38. Subgroup analyses showed comparable accuracy between singlemarker and panel-based assays, and serum samples yielded more consistent results. QUADAS-2 indicated acceptable methodological quality, and no significant publication bias was detected (p = 0.06).

Conclusion

Circulating miRNA-92a demonstrates superior diagnostic performance and considerable potential as a non-invasive biomarker for early CRC detection. Further large-scale prospective studies are required to standardize testing protocols and confirm their clinical applicability.

Schlagwörter

Stichwörter der Autor:innen

colorectal cancerdiagnostic accuracymeta-analysismiRNA-92anoninvasive biomarker

Autor:innen und Institutionen

  • Doctoral Program of Medical Science, Faculty of Medicine, Universitas Padjadjaran, Sumedang-Bandung, West Java, Indonesia.
  • Center for Biomedical Research, Research Organisation for Health, National Research and Innovation Agency (BRIN), Cibinong Science Centre, Cibinong-Bogor, West Java, Indonesia.
  • Division of Gastroenterohepatology, Department of Internal Medicine, Hasan Sadikin General Hospital, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.
  • Division of Digestive Surgery, Department of Gastroenterology, Hasan Sadikin General Hospital, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.
  • Department of Clinical Pathology, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia.
  • Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.

ORCID-Profile: Rosmeri Handayani, Siti Hamidatul Aliyah, Reno Rudiman, Ida Parwati

Zitieren

APA

Handayani, R., Aliyah, S. H., Bestari, M. B., Rudiman, R., Sukartini, N., & Parwati, I. (2026). Diagnostic Performance of Circulating miRNA-92a and Related Circulating miRNA Panels for Colorectal Cancer: An Updated Systematic Review and Meta-Analysis. OncoTargets and Therapy, Volume 19, 1-16. https://doi.org/10.2147/ott.s571818

Vancouver

Handayani R, Aliyah SH, Bestari MB, Rudiman R, Sukartini N, Parwati I. Diagnostic Performance of Circulating miRNA-92a and Related Circulating miRNA Panels for Colorectal Cancer: An Updated Systematic Review and Meta-Analysis. OncoTargets and Therapy. 2026;Volume 19:1-16. doi:10.2147/ott.s571818

BibTeX
@article{Handayani2026,
  author = {Handayani, Rosmeri and Aliyah, Siti Hamidatul and Bestari, Muhammad Begawan and Rudiman, Reno and Sukartini, Ninik and Parwati, Ida},
  title = {Diagnostic Performance of Circulating miRNA-92a and Related Circulating miRNA Panels for Colorectal Cancer: An Updated Systematic Review and Meta-Analysis},
  journal = {OncoTargets and Therapy},
  year = {2026},
  volume = {Volume 19},
  pages = {1--16},
  doi = {10.2147/ott.s571818}
}
Kostenlos starten →